Data / Form D filings / Epicore Biosystems, Inc.
Epicore Biosystems, Inc.: Form D filings
Epicore Biosystems, Inc., a biotechnology company in Cambridge, MA, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on April 7, 2025, reports $25.7 million sold of a $35 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 410 MEMORIAL DRIVE, SUITE 100, Cambridge, MA, 02139
- Phone
- (857) 529-7776
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1755876
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Amendment | $35,000,000 | $25,686,104 | $9,313,896 | 4 | Dec 11, 2024 | sec.gov |
| Jan 6, 2025 | New notice | $35,000,000 | $25,686,104 | $9,313,896 | 44 | Dec 11, 2024 | sec.gov |
| Feb 1, 2024 | New notice | $10,000,000 | $1,539,999 | $8,460,001 | 2 | Jan 19, 2024 | sec.gov |
| Feb 1, 2022 | Amendment | $10,000,000 | $9,500,000 | $500,000 | 5 | Nov 1, 2021 | sec.gov |
| Nov 3, 2021 | New notice | $10,000,000 | $4,650,000 | $5,350,000 | 4 | Nov 1, 2021 | sec.gov |
| Oct 16, 2018 | New notice | $1,000,000 | $350,000 | $650,000 | 1 | Oct 1, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Lee | Executive Officer | |
| James J. Ryan | Executive Officer | |
| Kimberly Querrey | Director | |
| John Wright | Executive Officer | |
| Jeffrey J. Model | Executive Officer | |
| Roozbeh Ghaffari | Executive Officer, Director | |
| John Rogers | Director | |
| Alexander J. Aranyosi | Executive Officer | |
| Weihua J. Li | Executive Officer | |
| Laura Lang | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Apr 7, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Epicore Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.